60 Degrees Pharmaceuticals (SXTP) Operating Leases (2023)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Operating Leases of $26800.0 for Q3 2023, down 32.1% quarter-over-quarter from $39470.0 in Q2 2023.
60 Degrees Pharmaceuticals (SXTP) Operating Leases (2023) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Operating Leases for 1 consecutive years, with $26800.0 the latest figure, recorded in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.01 Mn | 1.99 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 26,800.00 |
| Jun 30, 2023 | 39,470.00 |